Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bascoul-Mollevi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 17, 2008
Early stopping rules in clinical trials based on sequential monitoring of serious adverse eventsAndrew Kramar, C Bascoul-Mollevi
Statistics in Medicine|November 27, 2004
Two-part statistics with paired dataC Bascoul-Mollevi, S Gourgou-Bourgade, A Kramar
Computer Methods and Programs in Biomedicine|July 12, 2011
SAE: an R package for early stopping rules in clinical trialsC Bascoul-Mollevi, A Laplanche, M C Le Deley, et al.
Computer Methods and Programs in Biomedicine|March 17, 2018
Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTDC Bascoul-Mollevi, Marion Savina, Amélie Anota, et al.
Computer Methods and Programs in Biomedicine|December 8, 2021
%TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncologyE Charton, A Falcoz, E François, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 29, 2019
Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic reviewE Charton, B Cuer, F Cottone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenograftsC Larbouret, B Robert, C Bascoul-Mollevi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancerC Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
The Pharmacogenomics Journal|July 21, 2010
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancerA Ho-Pun-Cheung, E Assenat, C Bascoul-Mollevi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 17, 2008
Early stopping rules in clinical trials based on sequential monitoring of serious adverse eventsAndrew Kramar, C Bascoul-Mollevi
Statistics in Medicine|November 27, 2004
Two-part statistics with paired dataC Bascoul-Mollevi, S Gourgou-Bourgade, A Kramar
Computer Methods and Programs in Biomedicine|July 12, 2011
SAE: an R package for early stopping rules in clinical trialsC Bascoul-Mollevi, A Laplanche, M C Le Deley, et al.
Computer Methods and Programs in Biomedicine|March 17, 2018
Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTDC Bascoul-Mollevi, Marion Savina, Amélie Anota, et al.
Computer Methods and Programs in Biomedicine|December 8, 2021
%TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncologyE Charton, A Falcoz, E François, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 29, 2019
Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic reviewE Charton, B Cuer, F Cottone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenograftsC Larbouret, B Robert, C Bascoul-Mollevi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancerC Bascoul-Mollevi, S Gourgou, M-P Galais, et al.
The Pharmacogenomics Journal|July 21, 2010
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancerA Ho-Pun-Cheung, E Assenat, C Bascoul-Mollevi, et al.
Pageof 1